Report cover image

Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Publisher GlobalData
Published Sep 29, 2023
Length 157 Pages
SKU # GBDT18272406

Description

Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Contact Lenses pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Contact Lenses is a corrective, cosmetic or therapeutic lens which is placed on the cornea of the eye.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Contact Lenses under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Contact Lenses under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

157 Pages
    • Contact Lenses Overview
    • Contact Lenses - Pipeline Products by Stage of Development
    • Contact Lenses - Pipeline Products by Segment
    • Contact Lenses - Pipeline Products by Territory
    • Contact Lenses - Pipeline Products by Regulatory Path
    • Contact Lenses - Pipeline Products by Estimated Approval Date
    • Contact Lenses - Ongoing Clinical Trials
    • Contact Lenses Companies - Pipeline Products by Stage of Development
    • Contact Lenses – Companies Pipeline Products by Stage of Development
    • Aeon Astron Corporation Company Overview
    • Ai Kangte Medical Technology Co Ltd Company Overview
    • Alcon Inc Company Overview
    • Alcon Laboratories Inc Company Overview
    • Apeliotus Ophthalmics (Inactive) Company Overview
    • Axcelon Biopolymers Corp Company Overview
    • Azalea Vision Company Overview
    • Bar-Ilan University Company Overview
    • Bausch & Lomb Inc Company Overview
    • Bionode LLC Company Overview
    • Body Organ Biomedical Corp Company Overview
    • BVS Sight Inc Company Overview
    • Chinese Academy of Sciences Company Overview
    • Clerio Vision Inc Company Overview
    • Diopter Technologies Inc (Inactive) Company Overview
    • Euclid Systems Corp Company Overview
    • e-Vision Medical Devices, Inc. Company Overview
    • Eyenovations Company Overview
    • EyeYon Medical Company Overview
    • Fitlens Ltd Company Overview
    • iCheck LLC Company Overview
    • Imperial College London Company Overview
    • Industrial Science & Technology Network Inc Company Overview
    • Innovega Inc Company Overview
    • Johnson & Johnson Vision Care Inc Company Overview
    • Khalifa University Company Overview
    • Kubota Vision Inc Company Overview
    • Lentechs LLC Company Overview
    • Lipocoat BV Company Overview
    • Lynthera Corp Company Overview
    • Massachusetts Eye and Ear Infirmary Company Overview
    • McGowan Institute for Regenerative Medicine Company Overview
    • Menicon Co Ltd Company Overview
    • Mojo Vision Inc Company Overview
    • National University of Singapore Company Overview
    • Novartis AG Company Overview
    • Ocular Dynamics, LLC Company Overview
    • Ocutec Ltd Company Overview
    • Purdue University Company Overview
    • Queen's University Company Overview
    • RetMap Inc Company Overview
    • Shamir Optical Industry Ltd Company Overview
    • Smartlens Inc Company Overview
    • Stanford University Company Overview
    • SynergEyes Inc Company Overview
    • TECLens LLC Company Overview
    • Terasaki Institute for Biomedical Innovation Company Overview
    • The University of New South Wales press Limited Company Overview
    • University of California Company Overview
    • University of California San Diego Company Overview
    • University of New Hampshire Company Overview
    • University of Valencia Company Overview
    • University of Washington Company Overview
    • Verily Life Sciences Company Overview
    • Visioneering Technologies Inc Company Overview
    • VISTAKON Pharmaceuticals LLC Company Overview
    • Sep 08, 2023: Ocean Insight Names Richard Curran as President
    • Aug 30, 2023: CooperCompanies Announces Third Quarter 2023 Results
    • Aug 28, 2023: Novartis to Let Go 100 Employees in Latest Round of Layoffs
    • Aug 15, 2023: Alcon Reports Second Quarter 2023 Results
    • Jul 13, 2023: Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
    • May 15, 2023: Menicon Co. Notice of Agenda Items for the 66th Annual General Meeting of Shareholders
    • May 08, 2023: Hoya announces consolidated financial results for the fiscal year ended March 31, 2023
    • Apr 27, 2023: CooperCompanies announces release date for second quarter 2023
    • Apr 20, 2023: EssilorLuxottica reports Q1 2023 revenue
    • Feb 27, 2023: Menicon Notice Regarding Change in Representative Executive Officers and Personnel Changes in Executive Officers
    • Feb 23, 2023: Fielmann Announces Preliminary Figures for FY2022/Dividend
    • Feb 23, 2023: EssilorLuxotticaFY 2022 Results Year of records in sales, operating and net profit
    • Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
    • Feb 02, 2023: Cooper Companies Announces Release Date for First Quarter 2023
    • Feb 01, 2023: Novartis Announces Annual Report 2022
    • Feb 01, 2023: Newly launched multifocal colored contact lens 2WEEK Menicon Rei multifocal realizes natural vision from near to distance
    • Jan 31, 2023: Hoya Announces Fourth semi-annual financial statements
    • Jan 30, 2023: Yael Kusch Appointed Global Public Relations Manager Of Essilorluxottica
    • Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
    • Dec 19, 2022: CooperCompanies Sets Annual Meeting and Stockholder Record Dates
    • Nov 30, 2022: Elegance Optical International Holdings announces Interim Results for the Six Months Ended 30 September 2022
    • Nov 15, 2022: Bausch + Lomb reports more than 58 million units of contact lens, lens care and eye care materials collected through ONE By ONE and Biotrue eye care recycling programs
    • Nov 02, 2022: Fielmann AG: ad hoc announcement for the third quarter
    • Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring
    • Oct 13, 2022: Novartis to cut its Irish workforce by up to 25%
    • Oct 11, 2022: Elegance Optical International Announces Resignation of Executive Directors, Chairman of the Board and Authorised Representative
    • Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2
    • Sep 29, 2022: 1-800 Contacts Appoints Angie Balfour as Chief People Officer
    • Sep 29, 2022: QITIAN Technology Group Announces on the Appointment of Senior Management Personnel
    • Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations
    • Sep 28, 2022: Shanghai Conant Optical Co Ltd announced interim report for 2022
    • Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us